连接组织疾病与间歇性肺部疾病相关的rituximab:从免疫病变发生到治疗影响
Dimitrios Chatzis1, Aggelos Banos2,3, Antonis Fanouriakis2
12nd Pulmonary Medicine Department, University Hospital "Attikon", Athens Medical School, National and Kapodistrian University of Athens, 104 31 Athens, Greece.
International journal of molecular sciences
|January 10, 2026
概括
连接组织疾病相关的间歇性肺病 (CTD-ILD) 涉及自身免疫和纤维化. 抗CD20抗体利图西马布 (RTX) 消耗B细胞,并通过向关键免疫通路来治疗CTD-ILD显示有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
背景情况:
- 连接组织疾病相关的间歇性肺病 (CTD-ILD) 是一种严重的免疫媒介性肺病.
- 病原发生涉及自身免疫,炎症和纤维化,B细胞发挥着关键作用.
研究的目的:
- 审查CTD-ILD的免疫病原性机制.
- 详细介绍Rituximab (RTX) 在CTD-ILD中的作用方式.
- 总结CTD-ILD中RTX的临床证据.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 免疫病原性机制的分析.
- 对临床试验数据的评估.
主要成果:
- 乙细胞通过抗原呈现,自身抗体产生和宫外淋巴细胞组织形成对CTD-ILD病原发生的关键作用.
- 利图西马布 (RTX) 是一种B细胞消耗疗法,向这些致病机制.
- 不断发展的临床证据表明RTX是CTD-ILD的有前途的治疗剂.
结论:
- 了解B细胞参与是CTD-ILD病原体的关键.
- 利图西马布为CTD-ILD提供了有针对性的免疫调节方法.
- 进一步的临床研究正在进行中,以巩固RTX在控制CTD-ILD中的作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
478
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
478
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480
Connective Tissue Cell Types
4.0K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
473
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
473
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Rheumatic Heart Disease I: Introduction
422
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
422


